AstraZeneca (NDAs and U.S. Rights to 4 Pharmaceutical Products) is Buildings and Property in United Kingdom that focus on United States rights business. They cover business area such as a portfolio, marketing and sale right, pharmaceutical product, nda, United States right, relation, Atacand, Arimidex, Casodex.
-
United States Rights
-
1 Francis Crick Avenue
Cambridge CB2 0RE
England, United Kingdom
Private
a portfoliomarketing and sale rightpharmaceutical productndaUnited States rightrelationAtacandArimidexCasodex
* We use standard office opening hours in near AstraZeneca (NDAs and U.S. Rights to 4 Pharmaceutical Products)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
AstraZeneca (NDAs And U.S. Rights To 4 Pharmaceutical Products) is Buildings and Property business from United Kingdom that founded in - ( years old in ), AstraZeneca (NDAs and U.S. Rights to 4 Pharmaceutical Products) business is focusing on United States Rights.
AstraZeneca (NDAs and U.S. Rights to 4 Pharmaceutical Products) headquarter office and corporate office address is located in 1 Francis Crick Avenue Cambridge CB2 0RE England, United Kingdom.
AstraZeneca (NDAs and U.S. Rights to 4 Pharmaceutical Products) was founded in United Kingdom.
In , AstraZeneca (NDAs and U.S. Rights to 4 Pharmaceutical Products) is currently focus on United States rights sector.
Above is snippet of Google Trends for "United States rights" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with AstraZeneca (NDAs and U.S. Rights to 4 Pharmaceutical Products), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
